Dermatol. praxi. 2016;10(2):76-79 | DOI: 10.36290/der.2016.018

Current epidemiology and the treatment options of dermatophyte infection

doc. MUDr. Ivana Kuklová, CSc., Jiřina Stará, Kateřina Sedláková
Dermatovenerologická klinika 1. LF UK a VFN
V roce 2015 jsme provedli v mykologické laboratoři Dermatovenerologické kliniky 1. LF UK a VFN celkem 3 654 mykologických

A total of 3 654 samples were collected in the Mycological Laboratory of the Department of Dermatovenelogy, 1st Faculty of Medicine, Prague in 2015. T. rubrum was the most frequent dermatophyte isolated (91,5%), followed by T. interdigitalie (4,5%) and M. canis (1,8%). Less frequently isolated were A. benhamiae, T. tonsurans, E. floccosum a M. gypseum. The spectrum of dermatophytes is similar to previous years, there is a high proportion of antropophilic species, which corresponds to the composition of the urban population. This review discusses the current and future treatment options of dermatophytoses.

Keywords: dermatophytes, epidemiology, treatment

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuklová I, Stará J, Sedláková K. Current epidemiology and the treatment options of dermatophyte infection. Dermatol. praxi. 2016;10(2):76-79. doi: 10.36290/der.2016.018.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kuklová I, Kučerová H. Fungal infections in Prague, Czech Republic, between 1987 and 1998. Mycoses 2000; 44: 493-496. Go to original source... Go to PubMed...
    2. Havlickova B, et al. Epidemiological trends in skin mycoses worldwide. Mycoses, 2008; 51: 2-15. Go to original source... Go to PubMed...
    3. Buchta V, et al. Současné možnosti léčby kožních a slizničních mykóz. Prakt. lékáren. 2009; 5(6): 279-288.
    4. Janssen Pharma. SPORANOX(R) (itraconazole) Capsules. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020083s048s049s050lbl.pdf.
    5. Souhrn údajů o přípravku. Terbinafin Actavis 250 mg (Actavis Group Hf., Hafnarfjördur, Island), 2015 (www.sukl.cz).
    6. Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2007 Jul 18;(3): CD001434. Go to original source... Go to PubMed...
    7. Del Rosso JQ, Kircik LH. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol 2013; 12(11 Suppl): 165-171.
    8. Skořepová M, Hubka V,Polášková S, Stará J, Čmoková A. Naše první zkušenosti s infekcemi vyvolanými Arthroderma benhamiae (Trichophyton sp.). Čes-slov Derm, 2014; 89(4): 192-198.
    9. Tronnier H. Entzündliche Dermatomykosen-Therapie. Vergleich zwischen Naftifin und einem corticosteroidhaltigen Imidazol-Derivat. Mykosen 1985; 28(Suppl 1): 98-108. Go to PubMed...
    10. Girmenia, C. New generation azole antifungals in clinical investigation. Expert Opin Investig Drugs 2009; 18: 1279-1295. Go to original source... Go to PubMed...
    11. Gupta AK 1, Simpson FC. Investigational drugs for onychomycosis. Expert Opin Investig Drugs, 2014; 23(1): 97-106.
    12. Kumar S, Kimball AB. New antifungal therapies for the treatment of onychomycosis. Expert Opin Investig Drugs 2009; 18: 727-734. Go to original source... Go to PubMed...
    13. Voleková A. Antimykotiká v dermatológii. Dermatol. prax, 2012; 6(4): 152-157.
    14. Ghannoum M, Isham N, Herbert J, et al. Activity of TDT 067 (Terbinafine in Transfersome) against Agents of Onychomycosis, as Determined by Minimum Inhibitory and Fungicidal Concentrations. J Clin Microbio 2011; 49: 1716-1720. Go to original source... Go to PubMed...
    15. Smijs TG, Pavel S. The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum. Photochem Photobiol 2011; 87(1): 2-13. Go to original source... Go to PubMed...
    16. Galvan Garcia HR. Onychomycosis: 1064-nm Nd:YAG q-switch laser treatment. J Cosmet Dermatol. 2014; 13(3): 232-235. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.